Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 15;12(4):636.
doi: 10.3390/jpm12040636.

Investigation of the Relationship between Cardiovascular Biomarkers and Brachial-Ankle Pulse Wave Velocity in Hemodialysis Patients

Ping-Ruey Chou  1 , Pei-Yu Wu  2   3 , Ping-Hsun Wu  3   4 , Teng-Hui Huang  3 , Jiun-Chi Huang  2   3   4 , Szu-Chia Chen  2   3   4 , Su-Chu Lee  3 , Mei-Chuan Kuo  3   4 , Yi-Wen Chiu  3   4 , Ya-Ling Hsu  5 , Jer-Ming Chang  3   4 , Shang-Jyh Hwang  3   4
Affiliations

Investigation of the Relationship between Cardiovascular Biomarkers and Brachial-Ankle Pulse Wave Velocity in Hemodialysis Patients

Ping-Ruey Chou et al. J Pers Med. .

Abstract

Brachial−ankle pulse wave velocity (baPWV) and cardiovascular (CV) biomarkers are correlated with clinical cardiovascular diseases (CVDs) in patients with kidney disease. However, limited studies evaluated the relationship between baPWV and CV biomarkers in hemodialysis patients. This study investigated the relationship between circulating CV biomarkers and baPWV in patients on hemodialysis. Hemodialysis patients were enrolled between August 2016 and January 2017 for the measurement of baPWV, traditional CV biomarkers, including high-sensitivity troponin-T (hsTnT) and N-terminal pro-B-type natriuretic peptide (NT-proBNP), and novel CV biomarkers, including Galectin-3, Cathepsin D, placental growth factor, Endocan-1, and Fetuin-A. The independent association was assessed by multivariate-adjusted linear regression analysis to control for potential confounders. The final analysis included 176 patients (95 men and 81 women) with a mean age of 60 ± 11 y old. After adjusting for age and sex, hsTnT (p < 0.01), NT-proBNP (p = 0.01), Galectin-3 (p = 0.03), and Cathepsin D (p < 0.01) were significantly directly correlated with baPWV. The direct correlation with baPWV existed in multivariable linear regression models with a β of 0.1 for hsTnT and 0.1 for Cathepsin D. The direct relationship between baPWV and CV biomarkers, particularly with hsTnT and Cathepsin D, may be helpful for risk stratification of hemodialysis patients.

Keywords: brachial–ankle pulse wave velocity (baPWV); cardiovascular (CV) biomarkers; hemodialysis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Sample derivation flowchart.
Figure 2
Figure 2
Scatter plots with spline lines demonstrated selected CV biomarkers’ direct association with brachial–ankle pulse wave velocity in hemodialysis patients: (A) high-sensitivity troponin T (r = 0.5, p < 0.01); (B) N-terminal pro-brain natriuretic peptide (r = 0.2, p = 0.01); (C) Galectin 3 (r = 0.1, p = 0.1); (D) Cathepsin D (r = 0.2, p < 0.01).
Figure 3
Figure 3
The mean values of CV biomarkers in quartile groups of brachial–ankle pulse wave velocity among hemodialysis patients: (A) high-sensitivity troponin T (p for trend < 0.01); (B) N-terminal pro-brain natriuretic peptide (p for trend 0.01); (C) Galectin 3 (p for trend = 0.12); (D) Cathepsin D (p for trend = 0.02). Multiple comparisons were performed by Dunn’s multiple comparison test (a. significant difference from Q1; b. significant difference from Q2). Statistical significance was defined as p < 0.05.
See this image and copyright information in PMC

References

    1. Lv J.-C., Zhang L.-X. Prevalence and Disease Burden of Chronic Kidney Disease. Adv. Exp. Med. Biol. 2019;1165:3–15. doi: 10.1007/978-981-13-8871-2_1. - DOI - PubMed
    1. Glassock R.J., Warnock D.G., Delanaye P. The global burden of chronic kidney disease: Estimates, variability and pitfalls. Nat. Rev. Nephrol. 2016;13:104–114. doi: 10.1038/nrneph.2016.163. - DOI - PubMed
    1. Visseren F.L.J., Mach F., Smulders Y.M., Carballo D., Koskinas K.C., Bäck M., Williams B. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur. Heart J. 2021;42:3227–3337. doi: 10.1093/eurheartj/ehab484. - DOI - PubMed
    1. Vallianou N.G., Mitesh S., Gkogkou A., Geladari E. Chronic Kidney Disease and Cardiovascular Disease: Is there Any Relationship? Curr. Cardiol. Rev. 2019;15:55–63. doi: 10.2174/1573403X14666180711124825. - DOI - PMC - PubMed
    1. Provenzano M., Andreucci M., De Nicola L., Garofalo C., Battaglia Y., Borrelli S., Gagliardi I., Faga T., Michael A., Mastroroberto P., et al. The Role of Prognostic and Predictive Biomarkers for Assessing Cardiovascular Risk in Chronic Kidney Disease Patients. BioMed Res. Int. 2020;2020:2314128. doi: 10.1155/2020/2314128. - DOI - PMC - PubMed